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Do perceived barriers to clinical presentation affect anticipated time to 
presenting with cancer symptoms: An ICBP Study




Background: Cancer survival in the UK and Denmark are lower when compared to similar 
countries with late diagnosis a possible cause.  We aimed to study the relationship between 
barriers to attending a primary care physician (GP) and anticipated time to help seeking (ATHS) 
with four cancer symptoms in six countries. Method: A population-based survey measuring 
cancer awareness and beliefs conducted within the International Cancer Benchmarking 
Partnership in Australia, Canada, Denmark, Norway, Sweden and UK. Data were collected on 
perceived barriers to GP consultation (including embarrassment, worry about wasting the 
doctors time, fear about what the doctor might find and being too busy) and ATHS for persistent 
cough, abdominal swelling, rectal bleeding and breast changes. Relationships between 
perceived barriers and ATHS were investigated using multivariable analysis. Results: Among 
19,079 respondents, higher perceived barrier scores were associated with longer ATHS 
intervals for all symptoms studied (p<0.01) responders with the highest barrier scores (>10.84) 
had between two and three times the odds of longer ATHS. ATHS was low in Australia for all 
symptoms and highest in Denmark for abdominal bloating. Conclusion: Perceived barriers to 
help-seeking have a role in delaying GP presentation. Early diagnosis campaigns should 
address emotional and practical barriers that reduce early presentation with potential cancer 
symptoms. 
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The International Cancer Benchmarking Partnership (ICBP)1 was established to investigate and 
explain international variation in cancer survival. Survival rates for patients diagnosed between 
1995 and 2007 with lung, breast, bowel or ovarian cancer were persistently higher in Australia, 
Canada, and Sweden, intermediate in Norway, and lower in Denmark and the UK (England, 
Northern Ireland, and Wales)2. Survival deficits were most marked shortly after diagnosis. 
Comparisons of lung3, colorectal4 and breast5 cancer survival rates between the UK, Sweden 
and Norway have reported similar findings, which may partly be explained by later diagnosis in 
the UK. 
Patient delay in presenting to their primary care physician (GP) has been highlighted as an 
important component of the diagnostic interval for a number of cancers6. A systematic review of 
risk factors for delayed presentation with cancer symptoms identified a number of psychosocial 
factors associated with patient-mediated delay. These include perceived symptom seriousness, 
fear of cancer and embarrassment7. Similarly a UK study reported that emotional and practical 
barriers to GP presentation were associated with lower use of health services for symptoms 
patients worried might be cancer8. Factors for delayed presentation most commonly observed in 
Britain were difficulty making an appointment, worry about wasting the doctor’s time and worry 
about the diagnosis9.  Other studies reported delay to be associated with access to services10, 
lifestyle complexity, time, logistical considerations11, 12. In lung cancer, stigma of the disease 
related to internal self-blame has been highlighted as common13-14 and acts as an additional 
barrier to presentation15, 16, 17, 18. 
The ICBP collaboration has shown that while the UK has similar levels of cancer symptom 
awareness, the public perceived more barriers to help-seeking in the UK than in other countries 
studied19. The researchers suggest that interventions which address barriers and prompt earlier 
presentation in primary care should be developed and evaluated. The next step is to quantify 
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the role of barriers to help-seeking along the patient pathway to diagnosis in relation to different 
cancer symptoms and across different jurisdictions. This study used the international 
Awareness and Beliefs about Cancer (ABC) survey20 to compare the anticipated time to help 
seeking (ATHS) between countries and investigate how potential barriers to symptomatic 
presentation relate to anticipated help-seeking intervals. 
Method 
In 2011, the population-based ABC survey using computer-assisted telephone interviews with 
adults aged ≥50 years in six countries (Australia, Canada, Denmark, Norway, Sweden and the 
UK) was undertaken as part of the ICBP, to assess barriers to symptomatic presentation and 
ATHS. Details of the instrument and the survey methodology have been outlined previously20. 
Briefly the survey incorporated instruments to measure cancer awareness, cancer beliefs, 
barriers to help seeking and ATHS. Backward-forward translation was carried out in non-English 
speaking jurisdictions and equivalency of meaning testing was carried out with focus groups. 
Reliability and validity testing were also undertaken. 
Anticipated time to help-seeking 
The primary dependent variables studied were ATHS which was collected for four potential 
cancer symptoms: i) persistent cough, ii) breast changes, iii) rectal bleeding, and iv) abdominal 
bloating.  The interview instructions were: ‘I’m going to read you out a list of signs and 
symptoms; for each one can you tell me how long it would take you to go to the doctor from the 
time you first noticed the symptom.’  The responses were grouped into six time intervals (as 
soon as I noticed, up to 1 week, over 1 up to 2 weeks, over 2 up to 3 weeks, over 3 up to 4 
weeks, more than a month, would not contact a doctor). Respondents who said they would seek 
help from health professionals other than a GP (<1.3%), or answered ‘don’t know’ or ‘refused to 
respond’ (<3.5%), were removed from the analysis as the ATHS interval for these responses 
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was unclear. Age-sex adjusted comparisons of ATHS between countries were carried out using 
direct age standardisation. 
Barriers to symptomatic presentation 
The independent variable of interest in this study was an aggregate score of perceived barriers 
to symptomatic presentation to the GP.  The score consisted of four items: i) ‘I would be too 
embarrassed’, ii) ‘I would be worried about what the doctor might find’, iii) ‘I would be worried 
about wasting the doctor's time’, and iv) ‘I am too busy to make time to go to the doctor’. 
Respondents were asked, ‘could you say if any of these might put you off going to the doctor’ to 
which they could respond: ‘no’, ‘yes, sometimes’ or ‘yes, often’. The responses were scored as 
‘no’=0, ‘sometimes’=1 and ‘often’=2. An aggregate barriers score was calculated using results of 
the factor analysis outlined previously20 and presented on a scale with a minimum of 0 and 
maximum of 50. Respondents with incomplete data for the barrier items, or who answered ‘don’t 
know’ were excluded from the analysis (see Table 1). Almost half of the respondents reported 
no barriers, but those that did were categorised into tertiles (low: <3.75, medium: 3.75-10.84, 
high: >10.84). 
Other covariates 
Other covariates included sex, age, marital status (categorised as married/cohabiting vs 
single/divorced/separated/widowed), level of education mapped to UNESCO international 
standards for education (tertiary level qualification vs other)21, current smoking status (smoker 
or non-smoker) and country of residence.  Participants were also asked to report their perceived 
difficulty in arranging an appointment with a doctor, as ‘very difficult’, ‘somewhat difficult’, 
‘somewhat easy’ or ‘very easy’.  For analysis, this was dichotomised into ‘difficult’ or ‘easy’. In 
addition, the cancer beliefs measure comprising three items: ‘cancer can often be cured’, ‘a 
diagnosis of cancer is a death sentence’ and ‘people can expect to continue with normal 
activities and responsibilities’ was included in the analysis. 




The dependent variable, ATHS, was dichotomised so the cut-point for late presentation was set 
at the response category nearest the 80th percentile for the anticipated delay for each symptom 
to investigate the characteristics of those with the longest ATHS. The distribution of anticipated 
time from symptom onset to presentation to a GP varied by symptom type and is presented in 
Table 1. Cut-points for late presentation were set at: 4 weeks for both persistent cough (20.7% 
of respondents had ATHS of > 4 weeks) and abdominal bloating (16.5% of respondents), and 1 
week for both rectal bleeding (13.7% of respondents) and breast changes (13.6% of 
respondents). To determine the sensitivity of varying cut-points for ATHS on the relationship 
between barriers and anticipated time to help-seeking, cut-points were adjusted and the 
analysis was repeated. For persistent coughing and abdominal bloating the cut-point was 
adjusted from 4 weeks to 1 week while the cut-point for breast changes and rectal bleeding was 
adjusted from 1 week to 4 weeks. 
Univariate analysis with χ2 tests was undertaken to investigate factors associated with ATHS. 
Multivariable logistic regression modeling was used to test independence of associations 
between the aggregate barrier scores and ATHS for each cancer symptom, after adjusting for 
age, sex, having a tertiary qualification, smoking status, marital status, perceived ease of seeing 
a doctor, cancer beliefs and symptom recognition. Only variables that had a moderate 
association (p<0.25) with time to help seeking were retained in models. Models were also 
produced to determine sensitivity of associations to varying cut points for ATHS. 
Results 
The sample size was 19,079 (6,965 in the UK, 4,002 in Australia, 2,064 in Canada, 2,000 in 
Denmark, 2,009 in Norway and 2,039 in Sweden). The estimated response rate (after adjusting 
for the likely proportion of households that were eligible) varied between countries, ranging from 
16% in Canada to 38% in Denmark. Australia had a response rate of almost 36%, Norway, 
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23%, Sweden, 28% and the UK response rate was approximately 19%a. Like most population-
based surveys, men, people with lower educational attainment, and those from ethnic minority 
groups were under-represented22, 23.  Missing data ATHS and barrier responses were minimal 
(<2.5%). Over 50% of the participants in the study reported no perceived barriers.  
 
Significant variation between countries in age-sex adjusted ATHS was observed. No distinct 
patterns emerged for any of the four symptoms, although in Australia lower proportions of 
respondents reported long ATHS (defined as exceeded the specified cut points for each 
symptom) to help seeking for all four symptoms (Figure 1). The proportion of patients 
anticipating >4 weeks’ time to help seeking for a persistent cough was significantly lower in 
Sweden (17%) and Australia (16%). Fewer respondents (8%) in Sweden reported an ATHS 
interval >4 weeks before attending with abdominal bloating compared to 23% in Denmark and 
15% in all other countries. However, a larger proportion of respondents in Sweden reported an 
interval >1 week before attending with rectal bleeding (17%) compared to Australia (8%). Also, 
a larger proportion of respondents from Canada reported an ATHS interval >1 week for breast 
changes (21%), compared with all other countries (Figure 1). 
Univariate analyses (Table S1) showed significant associations between younger age, 
perceived difficulty in seeing the doctor, having a tertiary qualification, reporting ‘often’ or 
‘sometimes’ for each of four barriers to symptomatic presentation and higher likelihood of longer 
ATHS for all four symptoms. Holding more negative beliefs about cancer was also associated 
with a higher likelihood of longer ATHS, as assessed by the three item cancer belief measure 
(Table S1). 
  
                                                          
a Revised from the figures published in Forbes et al19 
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In multivariable analysis a higher barrier score was associated with longer ATHS, after adjusting 
for age, sex, having a tertiary qualification, smoking status, marital status, perceived ease of 
seeing a doctor, cancer beliefs and symptom recognition. Respondents with the highest barrier 
scores (>10.84) had between two and three times the odds of longer ATHS compared to those 
with no barriers for all symptoms. The relationship between country and ATHS varied by 
symptom. For persistent cough, compared to Australia, all other countries had increased odds 
of an ATHS interval >4 weeks with the odds highest for respondents from Norway. For 
abdominal bloating, respondents from Denmark had higher odds of an ATHS interval >4 weeks 
while the odds were lowest for respondents from Sweden (Table 2). Compared to Australia, all 
other countries had increased odds of an ATHS interval >1 week with rectal bleeding, with 
Norway and Sweden highest. Respondents in Canada had the highest odds of an ATHS interval 
>1 week with breast changes after accounting for other factors (Table 3).  
 
A strong positive association between barrier score and ATHS was observed across all 
countries for all four symptoms (Table S2 & S3) with the exception of breast changes in 
Canada. However, the effect size varied between countries with a statistically significant 
interaction between barrier and country for ATHS with breast changes, and an interaction 
approaching significance for abdominal bloating. For breast changes and abdominal bloating 
there was a particularly strong positive association between barrier score and time to help 
seeking in Sweden, with a more modest effect size in Canada and Norway.   
 
With regard to the individual barrier items, each barrier was associated with a longer ATHS 
interval for all four potential cancer symptoms. The association was graded such that the odds 
of anticipating a longer time to help-seeking increased across the three response options (from 
‘no’, to ‘sometimes’, to ‘often‘), with the greatest likelihood of late presentation in those 
responding ‘often'.  In adjusted analyses, the individual barrier associated with the highest odds 
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of a longer interval before help-seeking was responding ‘often’ to ‘being worried about wasting 
the doctor’s time’ for persistent cough and abdominal bloating and responding ‘often’ to being 
embarrassed’ for rectal bleeding and breast changes (Table S4). 
 
ATHS varied by symptom type, with a trend towards a longer interval for vague symptoms such 
as persistent coughing and abdominal bloating, and a shorter interval for breast changes and 
rectal bleeding. Sensitivity analysis was performed to determine the effect of varying the cut-
point for ATHS with an interval of >1 week for a persistent cough or abdominal bloating, and an 
interval of >4 weeks for rectal bleeding or breast changes. For all symptoms, barrier scores 
remained significantly associated with a longer ATHS interval in the model (Table S5). Similarly, 
patterns in the proportion of respondents reporting longer ATHS was similar in sensitivity 
analysis as when the original cut points were applied (Table S6). 
 
Discussion 
This large population-based international study allowed, for the first time, an investigation into 
variation in ATHS between countries and any association between perceived barriers to 
symptomatic presentation and ATHS for specific cancer symptoms.  
Significant variation in ATHS between countries and symptoms was found, which persisted after 
accounting for other factors. ATHS was shorter for alarm symptoms (rectal bleeding and breast 
changes) and longer for vague symptoms (coughing and abdominal pain). There was no 
consistent pattern in variation across all symptoms and patterns did not consistently correlate 
with cancer survival variation. The lack of association may be due to the influence of other 
factors such as delay later in the diagnostic pathway, co-morbid disease or variation in 
treatment. 
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 The lower proportions of respondents anticipating longer intervals with a persistent cough and 
rectal bleeding in Australia and abdominal bloating or breast changes in Sweden was not 
explained by barriers, symptom awareness or other factors in the study. These may be 
explained by other healthcare, cultural or social factors or differences in cancer awareness 
raising activities between countries and is worthy of further investigation. In addition, 
understanding the extent to which this variation in ATHS intervals to help seeking reflects actual 
patient behaviour would be of value.  It is unlikely that that the indicator of ATHS reflects true 
behaviour around help seeking with cancer symptoms.  
 
As in previous UK-based studies8, 9 there was an association between the level of endorsement 
of perceived barriers and the ATHS interval before help-seeking that remained after adjusting 
for other factors. However, the relationship varied by country. Barriers consistently had strong 
odds in explaining longer ATHS for all symptoms investigated. These findings further reinforce 
the importance of tailoring cancer awareness campaigns so that messages specifically address 
these barriers to presentation as well as deficits in symptom awareness. However, there was 
some heterogeneity between countries in the relationship between barriers and ATHS with 
breast changes with relatively modest effect size in Canada compared to Sweden. ATHS >1 
week with breast changes was particularly high in Canada; it appears that other factors such as 
symptom recognition and ease of visiting a doctor played a more prominent role in explaining 
variation in ATHS in Canada while these relationships were less marked in Sweden (data not 
presented). These population differences in barriers to help seeking highlight the importance of 
targeted country and perhaps region specific campaigns, tailored to the unique characteristics of 
each population. 
 
The study findings suggest that each of the four quite distinct barriers are important in their own 
right in explaining ATHS in help-seeking, though their relative importance varies by symptom 
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type. Embarrassment was more strongly associated with longer time to help-seeking for intimate 
symptoms such as breast changes and rectal bleeding, while worry about wasting the doctor’s 
time was a more important determinant of help-seeking for the more vague symptoms 
(persistent cough and abdominal bloating). These findings highlight the importance of ensuring 
that public campaigns aimed at reducing inappropriate help-seeking do not encourage 
unwarranted concern over wasting the doctor’s time, consequently contributing to barriers to 
presentation, which ultimately have the potential to lead to a diagnostic delay in cancer. 
 
It is also important to recognise that after accounting for barriers and beliefs, symptom 
recognition remained an important factor in each of the models in which it was included. This is 
consistent with several other studies which have highlighted the importance of symptom 
knowledge for early help-seeking for the cancers of interest in this study 24, 25, 26, 27, 28. These 
findings further support the suggestion that early diagnosis campaigns should address both 
awareness of cancer symptoms and barriers to presentation in the population. 
Barriers to presentation, symptom awareness and cancer beliefs cannot fully explain variation in 
ATHS intervals within different age groups and those with different educational attainment. 
Further work is needed to understand causes for variation in different population sub-groups 
with a view to developing more targeted interventions for at risk groups. 
 
Strengths & Weaknesses 
The survey used standard administration across 12 different jurisdictions providing a large 
international population-based sample. While response rates were low they were typical of 
those recent studies with similar methods. Although weighting addressed biases toward older 
people, women and those from higher socio-economic groups, other differences in non-
response characteristics may have influenced the study findings.  
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Although the ABC tool used in this study was not based on a specific theoretical model, it 
encompasses domains used in most of the help-seeking models and has performed well in 
reliability and validity testing20. While cultural differences may exist in interpretation and 
response to questions between countries, steps were taking to ensure equivalency of meaning 
of the items across different languages. The analysis has been able to account for variations in 
a range of demographic characteristics and cancer beliefs. The study was also sensitive to 
frequency with which each barrier was reported (‘sometimes’ or ‘often’), and unlike previous 
studies, the analyses were symptom-specific. The extent to which reported ATHS predicts 
patterns in actual delay is not unclear with some quite distinct differences between actual delay 
and educational attainment25, 27 or age27-33 to the associations reported here for ATHS. However, 
associations between smoking status and ATHS for persistent coughing reflected previous 
studies of actual delay. It is also reassuring that a previous study investigating actual help-
seeking with possible cancer symptoms observed a similar relationship for similar barriers8. 
Rather than providing a prediction of delay among cancer patients, ATHS provides an indicator 
of those who are most likely to delay. By focusing on the 20% of respondents who anticipate the 
longest delays, this study focuses on those expected to delay longest before a diagnosis of 
cancer. Further work is required to determine the validity of ATHS as an indicator of actual help 
seeking behaviour.  
 
By varying cut points to dichotomise the time to help-seeking, the method accounted for 
variation in time to help seeking for different symptoms, with a trend towards a longer interval for 
vague symptoms such as persistent coughing and abdominal bloating, and a shorter interval for 
breast changes and rectal bleeding. Sensitivity analysis confirmed the relationships between 
time to help seeking and barriers persisted when alternative cut points were applied and 
confirmed the relationship with cancer survival patterns regardless of cut point. 
 




Perceived barriers to presentation with symptoms contribute strongly to explaining variation in 
ATHS for cancer symptoms though the relationship varies by country, symptom time and socio-
demographic circumstance. This paper highlights the importance of addressing emotional and 
practical barriers that patients perceive to stand in the way of GP consultations, with a view to 
expediting diagnosis and improving cancer survival. 
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Key points 
 This study reports international variation in anticipated time to help seeking  
 Patterns are not consistent with international variation in cancer survival  
 Perceived barriers to clinical presentation with possible cancer symptoms are strongly 
associated with anticipated time to help seeking 
 Cancer awareness campaigns should be locally tailored and should target barriers to help 
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